There are nearly 500 natural compounds in marijuana and over 100 of those chemical compounds (thanks to a recent discovery) are called cannabinoids.

Cannabis compounds are being used to tackle kidney failure amongst diabetics in a major new research project. Researchers working on the Aberdeen University study, which is funded by Diabetes UK, will explore whether synthetic cannabinoid compounds can be used to make the kidneys respond better to insulin.

Insys Therapeutics Inc. announced Tuesday, July 5, that the United States Food and Drug Administration (FDA) has approved the company’s drug Syndros, an orally administered liquid formulation of the synthetic cannabinoid dronabinol, according to a release.

(CNN) - Could medical marijuana treat Alzheimer's patients? One recent study found THC, the psychoactive ingredient in cannabis, stimulates the removal of toxic plaque in the brain, a common feature of the disease.

A team of researchers has been given a $157,000 grant to study whether cannabinoids can help treat brain cancer.

Oxford University will be at the forefront of a multimillion-pound research program, which hopes to help develop new therapies for acute and chronic conditions by examining the effects of medical cannabis.

DALLAS – Researchers at UT Southwestern Medical Center report the most detailed 3-D structure to date of the brain receptor that binds and responds to the chemical at the root of marijuana’s high.

Dr. Raphael Mechoulam laid the scientific foundation upon which all modern cannabis knowledge is built.